May 02, 2014 – Biolux Research Ltd.
Vancouver, CANADA – Biolux Research Ltd., the developer of Light Accelerated Orthodontics™ technology and products, is pleased to announce the appointment of Celestica HealthTech as its manufacturing partner for commercialization of the new OrthoPulse™ product for significantly accelerating orthodontic tooth movement and reducing treatment timelines.
Celestica provides knowledge, expertise, and focus to end-to-end product lifecycle solutions for customers in such industry sectors as healthcare, computing and communications. Celestica is a world leader in contract manufacturing with approximately 30,000 employees and 20 manufacturing and design facilities worldwide. The company is headquartered in Toronto, Canada and is publicly listed with a reported 2013 revenue of $5.8 billion USD. For more information, please visit www.celestica.com.
Celestica’s Toronto operation has a rich manufacturing heritage that combines superior technical capabilities with flexible manufacturing capacity. They are recognized by their customers for outstanding execution and quality. Celestica delivers complete manufacturing services, from printed circuit assembly (PCA) to complex systems integration and configuration, all under the toughest of quality QMS and ISO standards.
“We are very pleased to work with Celestica as our manufacturing partner as we ramp-up for the commercial launch of our new OrthoPulse™ product,” states Kevin Strange, President and CEO of Biolux. “The Celestica team has been excellent to work with and we are very much aligned in our attention to design and manufacturing processes, leading to a top quality solution for orthodontic patients. In addition, the scalability of Celestica will ensure that they can handle planned volumes of our revolutionary product for accelerating orthodontic treatment.”
For More Information:
VP Global Sales and Marketing